HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Abstract
In contrast to activated CD4+ T cells, resting human CD4+ T cells circulating in blood are highly resistant to infection with human immunodeficiency virus (HIV). Whether the inability of HIV to infect these resting CD4+ T cells is due to the lack of a key factor, or alternatively reflects the presence of an efficient mechanism for defence against HIV, is not clear. Here we show that the anti-retroviral deoxycytidine deaminase APOBEC3G strongly protects unstimulated peripheral blood CD4+ T cells against HIV-1 infection. In activated CD4+ T cells, cytoplasmic APOBEC3G resides in an enzymatically inactive, high-molecular-mass (HMM) ribonucleoprotein complex that converts to an enzymatically active low-molecular-mass (LMM) form after treatment with RNase. In contrast, LMM APOBEC3G predominates in unstimulated CD4+ T cells, where HIV-1 replication is blocked and reverse transcription is impaired. Mitogen activation induces the recruitment of LMM APOBEC3G into the HMM complex, and this correlates with a sharp increase in permissivity for HIV infection in these stimulated cells. Notably, when APOBEC3G-specific small interfering RNAs are introduced into unstimulated CD4+ T cells, the early replication block encountered by HIV-1 is greatly relieved. Thus, LMM APOBEC3G functions as a potent post-entry restriction factor for HIV-1 in unstimulated CD4+ T cells. Surprisingly, sequencing of the reverse transcripts slowly formed in unstimulated CD4+ T cells reveals only low levels of dG dA hypermutation, raising the possibility that the APOBEC3G-restricting activity may not be strictly dependent on deoxycytidine deamination
AuthorsYa-Lin Chiu, Vanessa B Soros, Jason F Kreisberg, Kim Stopak, Wes Yonemoto, Warner C Greene
JournalNature (Nature) Vol. 435 Issue 7038 Pg. 108-14 (May 05 2005) ISSN: 1476-4687 [Electronic] England
PMID15829920 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Retracted Publication)
Chemical References
  • Gene Products, vif
  • Mitogens
  • Multiprotein Complexes
  • Proteins
  • Repressor Proteins
  • Ubiquitin
  • vif Gene Products, Human Immunodeficiency Virus
  • Ribonucleases
  • Nucleoside Deaminases
  • APOBEC-3G Deaminase
  • APOBEC3G protein, human
  • Cytidine Deaminase
Topics
  • APOBEC-3G Deaminase
  • Amino Acid Sequence
  • Base Sequence
  • CD4-Positive T-Lymphocytes (cytology, enzymology, metabolism, virology)
  • Cell Line
  • Cell Proliferation (drug effects)
  • Cytidine Deaminase
  • Cytoplasm (enzymology)
  • Enzyme Activation
  • Gene Products, vif (metabolism)
  • Genes, env (genetics)
  • HIV Infections (metabolism, virology)
  • HIV-1 (genetics, growth & development, physiology)
  • Humans
  • Lymphocyte Activation (drug effects)
  • Mitogens (pharmacology)
  • Molecular Sequence Data
  • Molecular Weight
  • Multiprotein Complexes (metabolism)
  • Nucleoside Deaminases
  • Organ Specificity
  • Proteins (chemistry, genetics, metabolism)
  • RNA Interference
  • Repressor Proteins
  • Ribonucleases (metabolism)
  • Ubiquitin (metabolism)
  • Virus Replication (physiology)
  • vif Gene Products, Human Immunodeficiency Virus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: